Jump to content

16α-Iodo-E2

From Wikipedia, the free encyclopedia
16α-Iodo-E2
Identifiers
  • (8R,9S,13S,14S,16R,17R)-16-iodo-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
CAS Number
PubChemCID
ChemSpider
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC18H23IO2
Molar mass398.284g·mol−1
3D model (JSmol)
  • C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)I)CCC4=C3C=CC(=C4)O
  • InChI=1S/C18H23IO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1
  • Key:SSYGGPAGDDGXAF-ZXXIGWHRSA-N

16α-Iodo-E2,or16α-iodoestradiol,is asynthetic,steroidal,potentestrogenwith slight preference for theERαover theERβthat is used inscientific research.[1][2]The KDof 16α-iodo-E2 for the ERα is 0.6 nM and for the ERβ is 0.24 nM, a 4-fold difference inaffinity,whereasestradiolis considered to have similar affinity for the two receptor subtypes.[2]Unlike the case of the much weakerestriol(16α-hydroxyestradiol), 16α-iodo-E2 is considered to be equipotent with estradiol in terms of estrogenic activity.[3]Radiolabeled[16α-125I]iodo-E2 has been employed inimagingto study theestrogen receptor.[4]

See also

[edit]

References

[edit]
  1. ^Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC (2004). "Structure-based design of estrogen receptor-beta selective ligands".J. Am. Chem. Soc.126(46): 15106–19.doi:10.1021/ja047633o.PMID15548008.
  2. ^abChen GG, Vlantis AC, Zeng Q, van Hasselt CA (2008). "Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer".Curr Cancer Drug Targets.8(5): 367–77.doi:10.2174/156800908785133150.PMID18690843.
  3. ^Hochberg RB, Zielinski JE, Duax WL, Strong P (1986). "The molecular structure of 16 alpha-iodo-17 beta-estradiol, a high affinity ligand for the estrogen receptor".J. Steroid Biochem.25(5A): 615–8.doi:10.1016/0022-4731(86)90002-6.PMID3795941.
  4. ^Cummins CH (1993). "Radiolabeled steroidal estrogens in cancer research".Steroids.58(6): 245–59.doi:10.1016/0039-128x(93)90069-y.PMID8212070.S2CID29080385.